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Abstract 
Unanchored polyubiquitin chains are emerging as important regulators of cellular physiology with diverse roles 
paralleling those of substrate-conjugated polyubiquitin. However tools able to discriminate unanchored 
polyubiquitin chains of different isopeptide linkages have not been described. We describe the design of a 
linker-optimised ubiquitin-binding domain hybrid (t-UBD) containing two UBDs, a ZnF-UBP domain in 
tandem with a linkage-selective UBA domain, which exploits avidity effects to afford selective recognition of 
unanchored Lys48-linked polyubiquitin chains. Utilising native MS to quantitatively probe binding affinities we 
confirm cooperative binding of the UBDs within the synthetic protein, and desired binding specificity for 
Lys48-linked ubiquitin dimers. Furthermore MS/MS analyses indicate that the t-UBD, when applied as an 
affinity enrichment reagent, can be used to favour the purification of endogenous unanchored Lys48-linked 
polyubiquitin chains from mammalian cell extracts. Our study indicates that strategies for the rational design 
and engineering of polyubiquitin chain-selective binding in non-biological polymers are possible, paving the 
way for the generation of reagents to probe unanchored polyubiquitin chains of different linkages and more 
broadly the ‘ubiquitome’.  
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Statement of significance 
Importance and functional significance of the research (max 200 words) 
Unanchored (substrate-free) polyubiquitin chains are naturally-occurring covalently-linked polymers of the 
ubiquitin protein which are emerging as important regulators of ubiquitin-mediated processes. However little is 
known about their composition/structure, assembly mechanisms and precise functions in part due to the inability 
of current molecular tools to distinguish unanchored polyubiquitin chains from the more widely characterised 
substrate-anchored forms. We reasoned it should be possible to design and synthesize a non-biological protein 
containing tandem ubiquitin-binding domains (natural ubiquitin recognition elements) which would exploit 
avidity effects to afford the selective recognition and purification of specific forms of unanchored polyubiquitin, 
Lys48-linked chains. We describe use of a computational design approach based on combination of existing 
molecular structures, the application of quantitative native mass spectrometry to define binding affinities, as 
well as a demonstration using MS/MS that the synthetic protein exhibits desired binding specificity in vitro and 
in cell extracts. This is the first exploration of the utility of this type of selective artificial tandem ubiquitin-
binding domain hybrid and indicates the rational design and engineering of more general polyubiquitin chain-
selective binding in non-biological polymers is viable.  Such reagents are essential for future mechanistic studies 
of ubiquitin-mediated signalling in vivo. 
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1 Introduction 
Ubiquitination, the covalent post-translational modification of target proteins with ubiquitin, is central to the 
regulation of a diverse array of biological processes [1]. Signalling versatility arises from the ability of ubiquitin 
to form eight structurally unique polyubiquitin chain types, which vary according to linkage (isopeptide and 
peptide) and chain length, on selected (usually) Lys residues within the substrate sequence [2]. However, more 
recently physiological roles for unanchored (substrate-free) polyubiquitin chains have also begun to emerge, for 
example with respect to regulation of protein kinase activity [3], innate immune signalling [4, 5], and the 
aggresome response [6, 7]. In each case non-covalent binding of unanchored polyubiquitin chains to specific 
effector proteins underlies the respective biological process targeted. As for ubiquitin signalling mediated via 
conjugated polyubiquitin, unanchored chains with different linkages translate in to different signalling 
outcomes. However, to date molecular tools to study this unanchored fraction of the ‘ubiquitome’ are limited. 
 
Non-covalent recognition of (poly)ubiquitin is afforded by a ‘tool box’ of ubiquitin-binding domains (UBDs) 
found within ubiquitin-binding proteins, including small helical structural motifs and zinc-finger domains [8], 
which recognise distinct surface patches on ubiquitin. The three-helix bundle ubiquitin-associated (UBA) 
domain typically recognises a hydrophobic patch centred on Ile44 of ubiquitin, while the zinc-finger ZnF A20 
domain binds specifically to the polar Asp58 face of ubiquitin [9]. The ZnF-UBP domain specifically targets the 
free C-terminus (Gly75/Gly76) of ubiquitin [10], thus distinguishing between conjugated polyubiquitin chains 
and those that are substrate-free. A limited number of isolated UBDs can decode polyubiquitin signals in a 
linkage-selective manner. The archetypal example is the UBA2 domain of hHR23A, a proteasome shuttle 
protein which recognises Lys48-linked chains by simultaneous binding to Ile44 sites on distal and proximal 
ubiquitins in a diubiquitin unit, via two binding faces on the same UBA [11]. More recently, natural UBDs 
selective for Lys29/Lys33-linked diubiquitin have also been identified [12]. Alternatively, linkage selectivity of 
ubiquitin-binding proteins can be achieved by placing multiple non-specific UBDs in tandem, with the linker 
region between them positioning the domains for efficient avid binding across different ubiquitins, which in the 
case of Rap80 achieves selective recognition of Lys63-linked polyubiquitin chains [13]. The deubiquitinating 
enzyme USP5 is a good example of a natural multi-UBD protein, with binding by a ZnF-UBP domain, catalytic 
site and two UBA domains promoting the selective recognition of unanchored polyubiquitin chains, over 
monoubiquitin, albeit independent of chain linkage [14].  
5 
 
Insights into the biological significance of different polyubiquitin assemblies, and the ubiquitin-mediated 
processes they regulate, have in part been afforded by exploiting the inherent specificities of UBDs as in vitro 
tools. We previously used the isolated ZnF-UBP domain of USP5 to allow the affinity purification of 
unanchored polyubiquitin from a range of different species [15, 16], whilst alternative UBDs have been widely 
utilised to purify or detect ubiquitin-modified proteins in vitro [17], and also to probe ubiquitin modifications in 
living cells [18], often with linkage selectivity.  Furthermore artificial protein sequences, termed Tandem 
Ubiquitin-Binding Entities (TUBEs), representing multiple repeats of the same (and very recently different [19]) 
UBD sequence have been developed as tools to probe polyubiquitin chains [20]. As for their natural 
counterparts, avidity effects account for the high affinity binding of TUBEs to polyubiquitin, although these 
polymers do not typically exhibit linkage selectivity [17]. In contrast, Sims and co-workers [13] have extended 
the Rap80 model and described the design of a Lys63 polyubiquitin chain-selective agent as a sensor for 
localisation and linkage-dependence of ubiquitin signalling by using multiple tandem natural ubiquitin 
interacting motifs (UIMs). Thus UBDs are in principle amenable to synthetic biology approaches involving 
assembly of tandem UBDs with engineered recognition properties. 
 
Indeed a future challenge is the development of bio-inspired synthetic reagents for the selective detection and 
purification of polyubiquitin chains of defined chain linkage/length, and which distinguish unanchored from 
conjugated polyubiquitin. Towards this goal we demonstrate the rational design and validation using different 
MS approaches, of a tandem UBD (t-UBD) hybrid protein containing a ZnF-UBP domain joined to a Lys48-
polyubiquitin-selective UBA domain, which exploits avidity effects to allow the recognition and purification of 
unanchored Lys48-linked polyubiquitin chains. This study serves as a first proof-of-concept that polyubiquitin-
selective recognition can be achieved using novel assemblies of differing UBDs in tandem with optimised 
linkage-selective avidity effects. 
 
2 Materials and methods 
2.1 t-UBD gene construction 
Molecular modelling (see supplementary information for details) was completed to determine the optimum 
linker length to join the UBA2 domain of hHR23A and the ZnF-UBP domain of USP16, to generate the t-UBD. 
Accordingly the codon optimised DNA coding sequence for the UBA2 of hHR23A (residues 315-362), a 
2xAsp4xGly linker and the ZnF-UBP domain of USP16 (residues 23-143) was assembled N to C terminally, 
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with BamHI and XhoI restriction sites included at the 5’ and 3’ ends respectively. The synthetic DNA was 
commercially sourced (Dundee Cell Products) and cloned in to the corresponding BamHI and XhoI sites of 
pGEX-4T-1 (GE Healthcare). Point mutations (ZnF-UBP-Arg84Ala and insertions/deletions at the linker of Gly 
residues) to the t-UBD gene were introduced by site-directed mutagenesis (QuikChange kit, Stratagene, Agilent, 
Stockport, UK), construct integrity was confirmed by DNA sequencing. 
 
2.2 Protein expression and purification 
The t-UBD (see supplementary information for detail), ZnF-UBP domain of USP5 (as per [15]) and 
monoubiquitin (WT and a mutant lacking the C-terminal Gly75 and Gly76 (ΔGG), as per [21]) were expressed, 
purified and desalted into 25 mM ammonium acetate (pH 7) in house. Desalted diubiquitin (Lys48 and Lys63 
linked, Boston Biochem) was commercially sourced.  
 
2.3 Native mass spectrometry 
Native ESI experiments were performed on a Waters (Altrincham, UK) Synapt G1 High Definition Mass 
Spectrometer (HDMS) - a hybrid quadrupole- time of flight instrument, equipped with standard electrospray 
source. The instrument was operated in positive-ion mode, over the scanning range of m/z 1000-4000. 
Instrument parameters were: ESI capillary voltage, 2.5 kV, sample cone voltage, 30 V, extraction cone voltage, 
5 V, trap and transfer collision voltage, 8 and 5 V respectively. Pressures maintained throughout the instrument 
were; backing pressure, 4-4.2 mBar, trap pressure, 2.5 × 10
−2
 mbar and TOF region pressure, 1.8 × 10
−6
 mbar. 
Waters MassLynx 4.1 software was used to operate the instrument and subsequently process data.  
 
Using ESI-MS, the binding affinity of the t-UBD for ubiquitin substrates was determined by titrating the 
ubiquitin substrate (1 μM) against the t-UBD at varying concentrations (2, 4, 6, and 8 μM) (three replicates at 
each titre value). Samples were prepared as 50:50 (v/v) solution mixtures in 25 mM ammonium acetate (pH 7) 
and directly infused into the mass spectrometer using a 100 μL Hamilton syringe (Bonaduz, Switzerland) and 
syringe pump (Harvard 22 dual syringe pump, model 55-2222 Holliston, MA, USA). Minimum smoothing and 
background subtraction was applied to the obtained spectra prior to analysis. Binding affinities were determined 
by comparing the ratios of signal intensities attributed to unbound (poly)ubiquitin and bound t-
UBD•(poly)ubiquitin ions (see [22] for details on Kd determination). 
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2.4 Pull-down assays 
Purified t-UBD or ZnF-UBP was immobilized to cyanogen bromide-activated Sepharose 4B (GE Healthcare) at 
equimolar concentration (t-UBD – 1.33 mg/ml; ZnF-UBP - 1 mg/ml) as previously described [15], wherein bait 
proves the limiting factor in the capture of unanchored polyubiquitin chains from cell extracts. t-UBD or ZnF-
UBP Sepharose was then used to capture either commercial diubiquitin or endogenous unanchored 
polyubiquitin from HEK293T cell lysates, as previously described [15] (see supplementary information for 
detail). Sepharose captures were then either western blotted, submitted to a deubiquitination assay, or digested 
with trypsin and analysed by LC-MS/MS. 
 
2.5 Western blotting 
50 μL of t-UBD or ZnF-UBP Sepharose captures were eluted into gel loading buffer, separated by 5-20% 
polyacrylamide SDS PAGE and immunoblotted against ubiquitin (VU-1, Life Sensors, PA, USA) or the Lys48 
polyubiquitin linkage (Apu-2, Millipore, Watford, UK), according to the manufacturer’s guidelines. Blots were 
detected by ECL (Western lightning plus, Perkin Elmer). 
 
2.6 Deubiquitination assay 
50 μL t-UBD or ZnF-UBP Sepharose captures were incubated overnight at 37°C, with 50 μL of full-length 
human USP5 (10 ng/μL, ENZO Life Sciences, Exeter, UK) or 50 μL of the catalytic core of the USP2 (25 
ng/μL, ENZO Life Sciences, Exeter, UK), in DUB buffer (50 mM Tris (pH 7.5), 1 mM DTT). The reaction was 
quenched with the addition of gel loading buffer, and immunoblotted against ubiquitin (VU-1). 
 
2.7 Protein digestion, analysis by tandem mass spectrometry and data processing 
Proteins affinity purified on t-UBD or ZnF-UBP Sepharose were eluted into 0.1% formic acid (pH 2), and 
digested according to a modified FASP strategy [23]. Briefly, eluate was buffer exchanged (Amicon ultra, 0.5 
ml, 10 kDa MWCO) into digestion buffer (2 M urea, 0.1 M ammonium bicarbonate (pH 8), 5% (v/v) 
acetonitrile), reduced (50 mM DTT), alkylated (100 mM chloroacetamide, Sigma, Dorset, UK) and digested 
with trypsin (sequencing grade modified porcine trypsin, Promega, Southampton, UK). After overnight 
digestion, peptides were extracted (70% acetonitrile, 0.1% formic acid) and vacuum centrifuged to dryness. LC-
MS/MS was carried out using an RSLC nano HPLC system (Dionex, UK) and an LTQ-Orbitrap-Velos mass 
spectrometer (Thermo Scientific) (see supporting information for detail on sample loading and analysis). 
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3 Results 
3.1 Designing and purifying the t-UBD 
We previously showed that the ZnF-UBP domain from the deubiquitinating enzyme USP5 recognises, with 
relatively high affinity, the free C-terminus of unanchored ubiquitin (Kd ≈ 2.3 μM vs monoubiquitin [22]), and 
can be used to affinity purify endogenous unanchored polyubiquitin chains from a range of biological sources 
[15, 16]. Importantly the specificity of the ZnF-UBP domain excludes the purification of conjugated 
polyubiquitin and associated covalently modified target proteins. However subsequent quantitative electrospray 
ionisation mass spectrometry (ESI-MS) interaction studies confirmed that this UBD exhibits no intrinsic 
selectivity for unanchored ubiquitin dimers or tetramers of different isopeptide linkages [22]. A further caveat to 
the use of the isolated ZnF-UBP domain in the purification of unanchored polyubiquitin is that it also fails to 
discriminate between free ubiquitin monomers and chains, the former of which predominate in vivo. Thus, 
purifications can be dominated by abundant monoubiquitin which can impact downstream analyses [15]. 
 
Here we describe the design of a novel synthetic t-UBD which for the first time utilises two different UBDs in 
tandem to exploit avidity effects that afford the selective recognition and purification of unanchored 
polyubiquitin chains of defined linkage. We reasoned that by utilising the ZnF-UBP domain (residues 23-143) 
of the deubiquitinating enzyme USP16 (Kd ≈ 6.5 M vs monoubiquitin [24]) in place of the ZnF-UBP domain 
of USP5 (Kd ≈ 2.8 M vs monoubiquitin) we would further disfavour recognition of monoubiquitin. Thus our 
construct included the ZnF-UBP domain (residues 23-143) of USP16 in tandem with the Lys48-selective UBA2 
domain of hHR23A (residues 315-362) [11]. Accordingly the ZnF-UBP domain of USP16 (pdb code 2I50) was 
modelled onto the existing USP5 ZnF-UBP:monoubiquitin complex (pdb code 2G45). This model guided 
docking of the ZnF-UBP domain on to the protruding free C-terminus of the proximal ubiquitin of the 
UBA2:Lys48-diubiquitin complex (pdb code 1ZO6). Molecular dynamic (MD) simulations were used (see 
supplementary information) to generate a sterically and energetically plausible model of the complex, which 
indicated a requirement for a linker length of at least 17 Å (equivalent to six residues) between the final 
structured C-terminal Phe360 residue of UBA2 and first structured N-terminal Val23 residue of the ZnF-UBP. 
We inserted a linker which accommodated the two native C-terminal aspartates from the UBA2 sequence (see 
supporting information Figure 1 for complete primary sequence). Thus, the final arrangement of the t-UBD 
placed the UBA2 domain N-terminal to the ZnF-UBP domain separated by a six amino acid (Asp2Gly4) flexible 
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linker (Figure 1). A plasmid for the expression of the t-UBD in E. coli was generated from the appropriate DNA 
sequence and used to produce the synthetic protein with an N-terminal GST affinity tag. Expressed protein was 
purified using glutathione-Sepharose, with t-UBD released using thrombin (with a residual N-terminal GlySer, 
from the thrombin cleavage site). Following purification, the construct was assessed by SDS-PAGE and mass 
spectrometry (supplementary Figure 2 and 3). 
 
3.2 Probing t-UBD specificity by native mass spectrometry 
To determine if the desired avidity effects were realised in the synthetic t-UBD protein, we performed native 
ESI-MS interaction studies in combination with protein mutagenesis. We used non-denaturing conditions to 
maintain non-covalent UBD:(poly)ubiquitin complexes in the gas phase [22], permitting binding affinities to be 
estimated from titration analyses. We have previously shown that this methodology gives affinities in excellent 
agreement with data derived from other biophysical techniques but with increased speed and reduced sample 
consumption [22]. Using ESI-MS we found that the t-UBD readily formed complexes with unanchored Lys48-
diubiquitin, binding with a Kd ≈ 1 μM, compared to Lys63-diubiquitin with Kd ≈ 9 μM (Figure 2, left and Table 
I) and monoubiquitin with Kd ≈ 11μM (Table I). Consistent with our ESI-MS data, protein pull-down assays 
using t-UBD Sepharose confirmed preferential capture of unanchored Lys48-diubiquitin compared to Lys63-
diubiquitin (Figure 2, right); in comparison, under the conditions used, the higher affinity (than USP16) isolated 
ZnF-UBP domain from USP5 was able to capture Lys63-diubiquitin (Kd = 2.8 ± 0.3 μM). 
 
Since the isolated UBA2 domain has a previously reported Kd vs Lys48-diubiquitin of ≈ 18 μM and vs 
monoubiquitin of ≈ 200 μM [22], and the ZnF-UBP (USP16) a Kd vs monoubiquitin of ≈ 6.5 μM [24], we 
rationalised the higher affinity (≈ 1 μM) interaction of the t-UBD with unanchored Lys48-diubiquitin results 
from both UBDs simultaneously recognising both ubiquitin units in the Lys48-linked dimer. Further, binding of 
the t-UBD to Lys63-diubiquitin with Kd ≈ 9 μM was entirely consistent with recognition of just the proximal 
ubiquitin by the ZnF-UBP and the functionality of that UBD. To test the contribution of both UBDs to 
recognition of unanchored Lys48-diubiquitin we mutated a critical Arg84 residue in the ZnF-UBP sequence of 
the t-UBD and assessed binding of the mutant. In this case an apparent Kd of ≈ 23 μM vs Lys48-diubiquitin 
(Table I), comparable to that we reported for the UBA2 alone (Kd ≈ 18 μM), is consistent with abrogating the 
ZnF-UBP interaction with only the UBA2 contributing to binding. The data suggests that tandem UBDs are 
contributing to an avidity effect which underlies high affinity recognition of Lys48-diubiquitin. Likewise, use of 
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a monoubiquitin mutant lacking the C-terminal Gly75 and Gly76, critical for recognition by the ZnF-UBP 
domain [24], produced an apparent Kd with the wild-type t-UBD of ≈ 198 μM (Table I), consistent with only 
weak binding at the UBA2. Thus, we can conclude that our engineered avidity effect contributes to a ≈ 11-fold 
preference of the t-UBD for unanchored Lys48-diubiquitin over monoubiquitin and that the t-UBD exhibits 
selectivity for Lys48-linked dimers (at least 7-fold over Lys63-linked dimers). It is noteworthy that selectivity of 
comparable magnitude is reported for the naturally occurring tandem UIMs of Rap80, which show an ≈ 24-fold 
selectivity for Lys63-diubiquitin over monoubiquitin [13].  
 
3.3 Optimising the t-UBD linker length  
We next assessed if our rational design strategy had arrived at the optimum flexible linker length connecting the 
UBA2 and ZnF-UBP domains for the recognition of unanchored Lys48-diubiquitin. Previous studies have 
shown that in the natural tandem UIM construct Rap80, the linker length and its structural integrity significantly 
modulates the affinity for Lys63-linked polyubiquitin chains through avidity effects, by controlling UIM 
orientation and the relative phasing of binding sites along the helix [13]. Accordingly, we used site-directed 
mutagenesis to determine the effects on Lys48-diubiquitin recognition by shortening or lengthening the six 
residue flexible linker in the t-UBD. t-UBD sequences with 4-8 residue linkers were produced and again native 
ESI-MS was used to estimate binding affinities vs unanchored Lys48-diubiquitin (Figure 3). We found that the 
addition or removal of a single Gly residue from the linker increased the apparent Kd values, thus diminishing 
the avidity effect. The addition or removal of two residues produced apparent Kd values of ≈ 10 μM, close to 
those reported for the isolated ZnF-UBP vs monoubiquitin (Kd  ≈ 6.5 μM [24]) suggesting a major contribution 
of only this domain to the binding event. We speculate that weaker binding with shorter and longer linkers 
presumably reflect clashes between the two UBDs, linker and diubiquitin (shortening) and higher entropic costs 
associated with ordering the linker upon binding (lengthening).  
 
3.4 Purification of endogenous unanchored polyubiquitin chains by the t-UBD 
We went on to assess the binding properties of the t-UBD with respect to the purification of endogenous 
unanchored polyubiquitin chains from mammalian cells. Western blot analyses confirmed that in comparison to 
the isolated ZnF-UBP domain from USP5, under bait-limiting conditions, the t-UBD displayed preferential 
capture of longer unanchored polyubiquitin chains from HEK293T cell extracts (Figure 4, grey triangle), as 
detected with both anti-ubiquitin (Figure 4A) or Lys48-polyubiquitin specific antibodies (Figure 4B). 
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Importantly analysis of the blots revealed a clear advantage of the t-UBD over the original isolated ZnF-UBP 
domain, with almost no capture of free monoubiquitin associated with the former, reflecting the lower binding 
affinity of the ZnF-UBP domain of USP16 (Figure 4A). The unanchored nature of the purified chains was 
confirmed by treatment of samples captured on beads with the broad spectrum deubiquitinating enzyme USP2 
(catalytic core, Figure 4D) and also full-length USP5 (Figure 4C), which is highly selective for substrate-free 
polyubiquitin [10]; in both cases chains were completely disassembled to ubiquitin monomers. There was no 
obvious preference of the t-UBD over the isolated ZnF-UBP domain for endogenous Lys48-diubiquitin 
although this may represent the relatively high abundance of this linkage in endogenous dimers [15]. The 
preferential binding to longer chains of the t-UBD over the isolated ZnF-UBP domain supports previous ESI-
MS data in which the UBA2 domain displays a higher affinity for tetraubiquitin vs diubiquitin (8 μM vs 18 μM) 
[22]. We speculate that as with tandem UIMs [13], the compact nature of long Lys48-linked chains may lead to 
increased avidity effects owing to simultaneous interaction of non-adjacent ubiquitins with the t-UBD. 
 
To confirm the identity of polyubiquitin linkages in the purified endogenous unanchored chain mixtures, we 
performed LC-MS/MS analyses of samples captured in parallel from HEK293T cells using the t-UBD compared 
to the isolated ZnF-UBP from USP5. From the ZnF-UBP captured samples we detected signature peptides, 
indicating a significant abundance of all seven isopeptide linkages of unanchored polyubiquitin chains (Lys6, 
Lys11, Lys27, Lys29, Lys33, Lys48, Lys63; Figure 5 – two biological replicas presented). The peptide 
sequences identified and representative MS/MS spectra can be found in supplementary Figures 4 and 5. 
Detection of Lys6, Lys27, Lys29 and Lys33 linkages represents the first direct demonstration that the 
endogenous unanchored polyubiquitin pool includes these chain types. Although we do not provide a 
quantitative description of relative abundance of signature peptides (and hence polyubiquitin linkage) in the 
endogenous unanchored polyubiquitin pool, the ~four-fold increase in the spectral count of Lys48 signature 
peptides in the samples produced using the t-UBD (Figure 5) strongly indicates linkage selectivity is maintained 
in these in vitro pull-down. 
 
4 Discussion 
Unanchored polyubiquitin chains are emerging as important regulators of cellular physiology, with diverse roles 
which parallel those of substrate-conjugated polyubiquitin. Seminal work from the Chen lab defined roles for 
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endogenous unanchored polyubiquitin chains with different linkages in the direct activation of some protein 
kinases [3]. Subsequently a variety of physiological roles have emerged [4-7, 25-27]. 
 
We previously exploited the isolated ZnF-UBP domain from USP5 to afford the first affinity purifications of 
endogenous unanchored polyubiquitin chains from a range of biological sources [15, 16]. Although the 
purification of conjugated polyubiquitin was excluded, the approach is however non-selective with respect to 
different polyubiquitin linkages and also is complicated by the capture of abundant free ubiquitin monomers 
which predominate in vivo. Here we show it is feasible to design synthetic reagents which exploit avidity effects 
to permit the recognition and purification of unanchored polyubiquitin chains of defined linkage, in this case 
Lys48, by placing a ZnF-UBP domain in concert with a linkage-selective UBA domain. Our design perspective 
built upon the structural insights that natural linkage-selectivity tandem UBD interactions have so far provided; 
avidity effects are a key factor in fine tuning polyubiquitin selectivity and can be used to disfavour binding to 
monomeric ubiquitin. Indeed utilising the lower affinity (than that of USP5) ZnF-UBP domain of USP16 in the 
t-UBD sequence (Kd vs monoubiquitin ≈ 6.5 μM), we were able to strongly disfavour the capture of 
monoubiquitin in pull-downs from cell extracts. 
 
Several lines of evidence support the notion that within the artificial t-UBD construct both UBDs are functional 
individually, and furthermore work cooperatively to afford higher affinity interactions with Lys48-diubiquitin. 
Most persuasively, ESI-MS interaction studies demonstrated binding of the t-UBD protein to unanchored 
Lys48-diubiquitin with an apparent Kd of ≈ 1μM, which is greater than that associated with either of the 
individual UBDs in isolation. In contrast, binding of t-UBD to unanchored Lys63-diubiquitin was of similar 
affinity to the isolated ZnF-UBP:monoubiquitin interaction, suggesting in this case simple recognition at the 
proximal ubiquitin in the dimer by the ZnF-UBP alone. Use of mutant monoubiquitin as ligand and mutagenesis 
of the ZnF-UBP domain within the t-UBD provided additional confirmation the functionality of both domains.  
 
As noted previously the magnitude of the avidity effect we generated (an ≈ 11-fold preference of the t-UBD for 
unanchored Lys48-diubiquitin over monoubiquitin) may appear relatively modest, but this is of a similar 
magnitude to that for the naturally occurring tandem UIMs in Rap80, which display an ≈ 24-fold preference for 
Lys63-diubiquitin over monoubiquitin [13]. Both our designed (t-UBD) and these natural (Rap80) UBDs do 
however represent the minimal tandem array, and indeed much higher affinity binding can be achieved by 
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placing multiple UBDs in tandem, as was achieved by Sims and co-workers using three identical UIMs in a 
single structured α-helix [13]. This similarly explains the high affinity (non-selective) polyubiquitin-binding 
properties of TUBEs (consisting of a tandem array of flexibly linked UBA domains). Thus, it should be possible 
to extend our design strategy to incorporate additional UBDs in order to promote further interactions which 
favour the recognition of longer unanchored polyubiquitin chains. Reassuringly, our modelling approach led to 
the optimum flexible linker length (with longer or shorter linkers associated with weaker binding), although it 
would be of interest to explore the effects on binding affinity of substituting rigid helical linkers to more tightly 
constrain the tandem UBD arrangement. Given that our MS/MS analyses using the isolated linkage-independent 
ZnF-UBP domain of USP5 alongside the t-UBD revealed that all of the ubiquitin isopeptide linkages participate 
in unanchored polyubiquitin chain formation in mammalian cells, we anticipate substituting other linkage-
selective UBDs for the UBA2 to permit the recognition, detection and purification of unanchored chains of all 
linkage type allowing further dissection of the linkage-selective roles of unanchored polyubiquitin in regulating 
cell physiology. 
 
In summary our work serves as proof-of-concept for the rational design of UBD hybrids with defined 
unanchored polyubiquitin selectivity, which we plan to evolve through further design iterations. We have 
demonstrated one application of the t-UBD, in the selective affinity purification of endogenous unanchored 
polyubiquitin chains, but such tools could easily be adapted beyond purification to generate probes to monitor 
dynamic changes in ubiquitination patterns in live cells or as transient inhibitors of ubiquitin-dependent 
pathways in vivo [17]. 
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Figure legends   
Figure 1: t-UBD structure. (Right) Model of the t-UBD hybrid protein produced by docking (guided by pdb 
code 2I50) the ZnF-UBP domain of USP16 (blue) on to the protruding free C-terminus of the proximal ubiquitin 
in a model of the hHR23A-UBA2:Lys48-diubiquitin complex (green (partly obscured), yellow; pdb code 
1ZO6). The distance between C-terminal Phe360 of UBA2 and N-terminal Val6 of ZnF-UBP (both red) was 
estimated as 17.2 Å and indicated an absolute minimum linker length of six residues. We subsequently included 
a six residue flexible linker, including four glycine residues (white) along with two C-terminal aspartates 
donated by the UBA2 sequence. (Left) Cartoon representation of the t-UBD model. 
 
Figure 2: Confirming the functionality of the t-UBD with unanchored ubiquitin dimers. (Left) 
Representative ESI-MS spectra showing the t-UBD (6 μM) in complex with Lys48 (top) or Lys63-linked 
(bottom) diubiquitin (1 μM). The t-UBD more readily forms complexes with unanchored Lys48-diubiquitin than 
with Lys63-diubiquitin, as evidenced by the stronger signal for bound complex in the Lys48-diubiquitin 
spectrum and for unbound t-UBD in the Lys63-diubiquitin spectrum. Titration analyses were used to estimate 
Kd values for the interactions (see Table I). (Right) Representative western blots (anti-ubiquitin) of protein pull-
down assays with equimolar t-UBD or isolated ZnF-UBP domain from USP5 (UBP) on beads, used to capture 
unanchored Lys48-diubiquitin or Lys63-diubiquitin. The t-UBD captures only Lys48-diubiquitin under these 
conditions. The higher affinity isolated ZnF-UBP domain (USP5) (Kd ≈ 3.6 M for Lys48-diubiquitin and 
2.8M for Lys63-diubiquitin [22]) is capable of capturing both dimers.  
 
Figure 3: Validating the t-UBD design strategy. Effects of shortening or lengthening the six residue t-UBD 
linker on the recognition of unanchored Lys48-diubiquitin. Site-directed mutagenesis was used to insert or 
delete one or two glycine residues within the t-UBD linker, and ESI-MS applied to estimate Kd values for the 
interaction with Lys48-diubiquitin.  
 
Figure 4: Application of t-UBD to the purification of endogenous unanchored polyubiquitin. Capture of 
endogenous unanchored Lys48-linked polyubiquitin chains using the t-UBD. Representative anti-ubiquitin 
western blots showing endogenous unanchored polyubiquitin chains, captured from mammalian HEK293T cell 
extracts, using equimolar t-UBD or isolated ZnF-UBP domain from USP5 (UBP) on beads (with protein on 
beads limiting). Grey circles indicate numbers of ubiquitins (#Ub) within the chains. (A) Probed with anti-
17 
 
ubiquitin. (B) Probed with Lys48-linked polyubiquitin-specific antibodies. (C) Captured unanchored 
polyubiquitin chains as in (A) treated with full-length USP5, which catalyses complete disassembly to 
monoubiquitin, confirming their unanchored nature (anti-ubiquitin). (D) Captured unanchored polyubiquitin 
chains as in (A) treated with USP2 catalytic core, which again catalyses complete disassembly to 
monoubiquitin, further confirming they represent polyubiquitin (anti-ubiquitin). 
 
Figure 5: Confirming the specificity of t-UBD in vitro. LC-MS/MS analyses confirm the identity of the 
polyubiquitin linkages in the purified endogenous unanchored polyubiquitin chains from HEK293T cells, 
captured in parallel using the t-UBD or linkage-independent ZnF-UBP domain (USP5) (two biological replicas 
presented). Purified samples on beads as in Figure 4, prepared using equimolar t-UBD or ZnF-UBP, were 
subject to tryptic digestion and LC-MS/MS analysis to identify polyubiquitin signature peptides. After custom 
database searching, only peptides corresponding to ubiquitin were identified. The data was manually 
interrogated for peptides modified with GlyGly (+114.042927 on Lysine) and LeuArgGlyGly (+383.228103 on 
Lysine). The bars represent total spectral count of each ubiquitin signature peptide during the analysis of each 
sample. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
18 
 
Table I – ESI-MS-derived dissociation constant (Kd) values for UBD: (poly)ubiquitin interactions 
 
 
monoubiquitin 
ΔGlyGly-
monoubiquitin 
Lys48-diubiquitin Lys63-diubiquitin 
 
UBA2
a
 200 ± 14 nd 18 ± 2 126 ± 18 
ZnF-UBP
b
 6.5 nd nd nd 
t-UBD 10.9 ± 0.4 197.5 ± 4.3 1.3 ± 0.3 9.9 ± 1.5 
t-UBD (ZnF-UBP) 
mutant 
nd nd 23 ± 1.8 nd 
 
The Kd values reported here for the t-UBD (mean ± SD, M) were averaged from values measured at different 
concentrations; nd - not determined. Values generated in this study are shaded. 
a
Determined by ESI-MS [22]. 
b
Determined by ITC [24]. Note that values of the t-UBD versus Lys63-diubiquitin and monoubiquitin are 
consistent with only the ZnF-UBP making a major contribution to binding in these cases. 
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Supplementary information 
 
t-UBD molecular modelling 
The initial model of the ZnF-UBP domain in complex with monoubiquitin was generated using MOLMOL [1] 
by overlaying the NMR structure of the ZnF-UBP domain of USP16 (pdb 2I50) [2] with the related ZnF-UBP 
domain of USP5 in complex with monoubiquitin (pdb 2G45) [3]. The resulting model of the complex was then 
overlaid with the proximal ubiquitin of Lys48-linked diubiquitin in complex with the UBA2 domain of hHR23A 
(pdb 1ZO6) [4] to generate a ternary complex model of the two UBDs in complex with Lys48-linked 
diubiquitin. The ternary complex model was optimized thermodynamically via energy minimization using an 
AMBER10 force field in MOE (Molecular Operating Environment (MOE) 2014.10 Chemical Computing 
Group Inc., Montreal, Canada). The subsequent model was analysed to assess the optimal linkage strategy for 
the two UBDs based on the distance between the N and C-terminal residues of the ZnF-UBP and UBA domain 
respectively, and the average distance spanned by disordered loops found in the PDB database.  Linkers of 5-7 
residues were modelled using the general loop building procedure of the MOE Homology Modeller and 
minimized in MOE [5]. A 5-residue linker caused significant steric clashes while the 6 and 7 residue linkers 
were well tolerated.  
 
t-UBD expression and purification 
Competent BL21 cells were transformed with the GST-t-UBD expression plasmid and grown in Luria broth 
(LB) medium, supplemented with ampicillin, at 37°C. Cultures were incubated until OD600 ≈ 0.6 and induced 
with 0.2 mM IPTG at 20°C for ≈ 16 hours. Bacteria were harvested by centrifugation and re-suspended in lysis 
buffer (10 mM Tris (pH 7.5), 150 mM NaCl, 0.1% (v/v) Triton X-100) supplemented with DNAseI (Sigma) and 
protease inhibitor cocktail (Sigma). The re-suspension was then lysed by sonication and clarified by 
centrifugation. Soluble GST-t-UBD was affinity purified on glutathione-Sepharose 4B (GE Healthcare) for 1 
hour at 4°C. Following the binding step, the Sepharose was washed with thrombin cleavage buffer (20 mM Tris 
(pH 8.4), 150 mM NaCl, 2.5 mM CaCl2) and incubated with thrombin (Sigma) for 16 hours at 4°C. Thrombin 
cleaved t-UBD, was further purified by anion exchange chromatography into 5 mM potassium phosphate buffer, 
with an increasing NaCl gradient. Fractions containing purified t-UBD were identified by SDS-PAGE and 
subsequent Coomassie staining, pooled and concentrated by ultrafiltration using Vivaspin 20 columns (10 kDa 
MWCO) (GE Healthcare) into 25 mM ammonium acetate (pH 7). 
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Purification of endogenous unanchored polyubiquitin 
Untreated HEK293T cells (grown to ≈ 70% confluence) were scraped into homogenising buffer (50 mM Tris, 
(pH 7.5), 150 mM NaCl, 0.5% (v/v) NP-40) supplemented with N-ethylmaleimide (NEM; 5 mM), MG-132 (20 
μM), mammalian protease inhibitor cocktail and mammalian phosphatase inhibitor cocktail (both 0.1% (v/v) 
respectively). The resuspension was sonicated, clarified by centrifugation (13,000 rpm, 10 min, 4°C) and the 
supernatant passed through glass wool. The protein concentration of the lysate was determined using a Thermo 
Scientific Pierce BCA Protein Assay Kit, prior to quenching excess NEM (DTT, [10 mM]). The lysate was 
heated at 75°C for 20 minutes and centrifuged (13,000 rpm, 10 min, 4°C). The supernatant (from 15 mg 
unheated lysate) was incubated with 100 μl of t-UBD or ZnF-UBP Sepharose overnight, washed in 
homogenising buffer and then with deubiquitination (DUB) buffer (50 mM Tris (pH 7.5), 1 mM DTT). 
 
LC-MS/MS methods 
LC-MS/MS was carried out using an RSLCnano HPLC system (Dionex, UK) and an LTQ-Orbitrap-Velos mass 
spectrometer (Thermo Scientific). Samples were loaded at high flow rate onto a reverse-phase trap column 
(0.3mm i.d. x 1mm), containing 5μm C18 300 Å Acclaim PepMap media (Dionex) maintained at a temperature 
of 37 °C. The loading buffer was 0.1% formic acid / 0.05% trifluoroacetic acid / 2% acetonitrile. Peptides were 
eluted from the trap column at a flow rate of 0.3 µl/min and through a reverse-phase PicoFrit capillary column 
(75μm i.d. x 400mm) containing Symmetry C18 100 Å media (Waters, UK) that was packed in house using a 
high pressure device (Proxeon Biosystems, Denmark). Peptides were eluted over a period of two hours, with the 
output of the column sprayed directly into the nanospray ion source of the LTQ-Orbitrap-Velos mass 
spectrometer. 
The LTQ-Orbitrap-Velos mass spectrometer was set to acquire a 1 microscan FTMS scan event at 60000 
resolution over the m/z range 300-1800 Da in positive ion mode. The maximum injection time for MS was 500 
ms and the AGC target setting was 1e
6
. Accurate calibration of the FTMS scan was achieved using a 
background ion lock mass for C6H10O14S3 (401.922718 Da). Subsequently up to 10 data dependent HCD 
MS/MS were triggered from the FTMS scan. The isolation width was 2.0 Da, normalized collision energy 42.5. 
Dynamic exclusion was enabled. The maximum injection time for MS/MS was 250 ms and the AGC target 
setting was 5e
4
.   
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The .raw data file obtained from each LC-MS/MS acquisition was processed using Proteome Discoverer 
(version 1.4.0.288, Thermo Scientific), searching each file in turn using Mascot  (version 2.2.04, Matrix Science 
Ltd.) [6] against a custom UniprotTB_20140416 database (unknown version, 3997 entries) [7], to which the 
human ubiquitin sequence was added. The peptide tolerance was set to 10 ppm and the MS/MS tolerance was 
set to 0.02 Da. Fixed modifications were set as carbamidomethyl (+57.021464 on cysteine) and variable 
modifications set as oxidation (+15.994915 on methionine), GlyGly (+114.042927 on Lysine) and 
LeuArgGlyGly (+383.228103 on Lysine). A decoy database search was performed. The output from Proteome 
Discoverer was further processed using Scaffold Q+S [8] (version 4.4.1.1, Proteome Software). Upon import, 
the data was searched using X!Tandem [9] (The Global Proteome Machine Organization). PeptideProphet [10] 
and ProteinProphet [11] (Institute for Systems Biology) probability thresholds of 95% were calculated from the 
decoy searches and Scaffold was used to calculate an improved 95% peptide and protein probability threshold  
based on the data from the two different search algorithms. Peptide Probabilities from Mascot were assigned by 
the Scaffold Local FDR algorithm. Proteins that contained similar peptides and could not be differentiated based 
on MS/MS analysis alone were grouped to satisfy the principles of parsimony. Proteins sharing significant 
peptide evidence were grouped into clusters.  
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Supplementary Figure 1: Primary sequence of the t-UBD. The N-terminal Gly-Ser overhang, residual from 
thrombin cleavage product is indicated, followed by residues 315-362 of hHR23A UBA2 (blue), a four Gly 
linker (in addition to the two Asp residues C-terminal of the UBA2 domain) and residues 23-143 of the ZnF-
UBP domain of USP16 (green). F and V (bold) represent the C-terminal Phe360 of UBA2 and N-terminal Val6 
of ZnF-UBP, respectively. R (red) represents the Arg84 of the ZnF-UBP domain which was mutated to abrogate 
binding at this domain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
GSQEKEAIERLKALGFPESLVIQAYFACEKNE
NLAANFLLSQNFDDGGGGVCRHIRKGLEQGNL
KKALVNVEWNICQDCKTDNKVKDKAEEETEEK
PSVWLCLKCGHQGCGRNSQEQHALKHYLTPRS
EPHCLVLSLDNWSVWCYVCDNEVQYCSSNQLG
QVVDYVRKQAS 
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Supplementary Figure 2: Purification of the t-UBD reagent. A) A representative Coomassie stained SDS-
PAGE gel of purified t-UBD. B) Spectra of WT and mutant t-UBD sprayed from 80 % MeCN, 0.1 % Formic 
acid. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A) B) 
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Supplementary Figure 3: Spectra of t-UBD linker mutations. Spectra of t-UBD linker mutants sprayed from 
80 % MeCN, 0.1 % formic acid. The mutation is indicated to the right. 
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Supplementary Figure 4: The signature ubiquitin tryptic peptides identified by MS/MS analysis of purified 
unanchored polyubiquitin. Additionally it has been reported that a minimal population of LRGG modified 
peptides result from trypsin missed cleavage.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Linkage Signature peptide 
K6 MQIFVK(GG)TLTGK 
K11 TLTGK(GG)TITLEVEPSDTIENVK 
K27 TITLEVEPSDTIENVK(GG)AK 
K29 AK(GG)IQDK 
K33 IQDK(GG)EGIPPDQQR 
K48 LIFAGK(GG)QLEDGR 
K63 TLSDYNIQK(GG)ESTLHLVLR 
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Supplementary Figure 5: Representative MS/MS spectra of the purified polyubiquitin linkages. MS/MS 
spectra of different polyubiquitin signature peptides as indicated derived from a sample of endogenous 
unanchored polyubiquitin captured from HEK293T cells using the linkage-independent isolated ZnF-UBP 
domain of USP5. 
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